315 related articles for article (PubMed ID: 26503953)
1. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
[TBL] [Abstract][Full Text] [Related]
2. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease.
Roy B; Neumann RS; Snir O; Iversen R; Sandve GK; Lundin KEA; Sollid LM
J Immunol; 2017 Jul; 199(2):782-791. PubMed ID: 28600290
[TBL] [Abstract][Full Text] [Related]
4. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
[TBL] [Abstract][Full Text] [Related]
5. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
6. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
[TBL] [Abstract][Full Text] [Related]
7. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T; Hietikko M; Salmi T; Lindfors K
Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
10. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
11. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells.
Iversen R; Di Niro R; Stamnaes J; Lundin KE; Wilson PC; Sollid LM
J Immunol; 2013 Jun; 190(12):5981-91. PubMed ID: 23690478
[TBL] [Abstract][Full Text] [Related]
14. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease.
Amundsen SF; Stamnaes J; du Pré MF; Sollid LM
Eur J Immunol; 2022 Sep; 52(9):1474-1481. PubMed ID: 35715890
[TBL] [Abstract][Full Text] [Related]
16. Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
Di Niro R; Snir O; Kaukinen K; Yaari G; Lundin KE; Gupta NT; Kleinstein SH; Cols M; Cerutti A; Mäki M; Shlomchik MJ; Sollid LM
Mucosal Immunol; 2016 Jan; 9(1):254-64. PubMed ID: 26153762
[TBL] [Abstract][Full Text] [Related]
17. TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.
Lindstad CB; Dewan AE; Stamnaes J; Sollid LM; du Pré MF
PLoS One; 2021; 16(11):e0259082. PubMed ID: 34731200
[TBL] [Abstract][Full Text] [Related]
18. Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease.
Lindeman I; Høydahl LS; Christophersen A; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM; Iversen R
Cell Rep; 2024 Apr; 43(4):114045. PubMed ID: 38578826
[TBL] [Abstract][Full Text] [Related]
19. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
20. Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing.
Snir O; Mesin L; Gidoni M; Lundin KE; Yaari G; Sollid LM
J Immunol; 2015 Jun; 194(12):5703-12. PubMed ID: 25972486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
